Jianhao Xu

529 citations
25 papers · 382 indexed · h-index 11
Topics
Cancer-related molecular mechanisms research (7 papers)MicroRNA in disease regulation (3 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Jianhao Xu

21 papers receiving 376 citations

Peers

Jianhao Xu
Comparison fields: 5 of 77
  • Molecular Biology 153
  • Cancer Research 116
  • Oncology 76
  • Obstetrics and Gynecology 43
  • Pharmacology 39
Replace Helene Hildegard Heidegger with:
Helene Hildegard Heidegger Germany
Hui-Wen Chang Taiwan
Manal L. Louka Egypt
Xiaobo Wang China
Dagmar Richter Germany
Liwei Ni China
Rick D. Fannin United States
Zhao Liu China
Da Wo China
Jianhao Xu relative to Helene Hildegard Heidegger Germany Helene Hildegard Heidegger's profile →
Citations per field
00.5×1.5×
Helene Hildegard Heidegger · 1×
Citations per year

Countries citing papers authored by Jianhao Xu

Since Specialization
Citations

This map shows the geographic impact of Jianhao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianhao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianhao Xu more than expected).

Fields of papers citing papers by Jianhao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianhao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianhao Xu. The network helps show where Jianhao Xu may publish in the future.

Co-authorship network of co-authors of Jianhao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianhao Xu. A scholar is included among the top collaborators of Jianhao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianhao Xu. Jianhao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 0
5 3
6 22
7 13
8 21
9 4
10 34
11 0
12 2
13 6
14 41
15 59
16 37
17 9
18 7
19 40
20 2

About Jianhao Xu

Jianhao Xu is a scholar working on Cancer Research, Biological Psychiatry and Obstetrics and Gynecology, having authored 25 papers that have together received 382 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Cancer Research (116 citations), Obstetrics and Gynecology (43 citations) and Oncology (76 citations). Jianhao Xu has collaborated with scholars based in China and United States. Frequent co-authors include Yusong Zhang, Jialong Tao, Liwei Ni, Na Yu, Yuming Long, Anqi Jin, Cunjin Su, Aiming Shi, Jie Pan and Ze Xiang. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Biochemical and Biophysical Research Communications and Atmospheric Environment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026